Comparative Study of Latanoprost Drug Delivery Systems for Glaucoma Treatment and Their Interaction with the Tear Film Lipid Layer Models
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.3c00635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Maria Chiara Saija und 6 weiteren Autor:innen. Beteiligte Einrichtung: J. Heyrovský Institute of Physical Chemistry, Czech Academy of Sciences, Dolejškova 3, 18223 Prague, Czech Republic. Hauptthemen laut MEDLINE: Eye, Glaucoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Grantov? Agentura Cesk? Republiky.
Abstract (Originalsprache)
This study investigates the interaction of two approved and one newly developed latanoprost formulation with in vitro and in silico models of the tear film and tear film lipid layer (TFLL). Latanoprost, a prostaglandin analogue used for intraocular elevated pressure treatment, is topically delivered by nanocarriers within aqueous solutions or emulsions. The study focuses on the impact of these carriers on drug interactions with the tear film and their effect on the TFLL. Three different types of latanoprost carriers, micellar, nanoemulsion, and polymer-based, were compared, and each revealed distinct interaction patterns with the TFLL. Surface pressure kinetics demonstrated a rapid increase for the benzalkonium chloride formulation and a slow rise for the preservative-free variants. Visualization of the acellular in vitro TFLL model revealed different patterns of incorporation for each formulation, indicating unique interaction mechanisms. Molecular dynamics simulations further revealed different mechanisms of drug release in the TFLL between micellar and nanoemulsion formulations. In-depth examination highlighted the role of triglyceride molecules in replenishing the nonpolar layer of the TFLL, which suggests potential improvements in ocular surface compatibility by adjusting the quality and concentration of the oily phase. These findings suggest the potential for optimizing latanoprost formulations by tuning the oily phase-to-surfactant ratio and selecting suitable surfactants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- J. Heyrovský Institute of Physical Chemistry, Czech Academy of Sciences, Dolejškova 3, 18223 Prague, Czech Republic.
- Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Hlavova 8, 12800 Prague, Czech Republic.
- SANTEN SAS, Novagali Innovation Center, 1 rue Pierre Fontaine, Bâtiment Genavenir IV, Evry Cedex F-91458, France.
ORCID-Profile: Katarina Vazdar, Agnieszka Olżyńska, Lukasz Cwiklik
Förderung
- Grantov? Agentura Cesk? Republiky
Zitieren
APA
Saija, M. C., Vazdar, K., Pajerski, W., Olżyńska, A., Daull, P., Garrigue, J. S., & Cwiklik, L. (2024). Comparative Study of Latanoprost Drug Delivery Systems for Glaucoma Treatment and Their Interaction with the Tear Film Lipid Layer Models. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00635
Vancouver
Saija MC, Vazdar K, Pajerski W, Olżyńska A, Daull P, Garrigue JS, et al. Comparative Study of Latanoprost Drug Delivery Systems for Glaucoma Treatment and Their Interaction with the Tear Film Lipid Layer Models. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.3c00635
BibTeX
@article{Saija2024,
author = {Saija, Maria Chiara and Vazdar, Katarina and Pajerski, Wojciech and Olżyńska, Agnieszka and Daull, Philippe and Garrigue, Jean-Sebastien and Cwiklik, Lukasz},
title = {Comparative Study of Latanoprost Drug Delivery Systems for Glaucoma Treatment and Their Interaction with the Tear Film Lipid Layer Models},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.3c00635}
}
EUVIMED